TB006 Expanded Access (EA) Compassionate Use

Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects

NCT04920786 ·Status: COMPLETED ·Phase: PHASE1

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

NCT01254448 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

NCT01690195 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease

NCT01482845 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease

NCT01966666 ·Status: COMPLETED ·Phase: PHASE1

Open Label Study of TRx0014 in Alzheimer's Disease

NCT00684944 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

NCT01023685 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

NCT00069849 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT01549834 ·Status: COMPLETED ·Phase: PHASE2

A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease

NCT02353598 ·Status: COMPLETED ·Phase: PHASE1

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

NCT00733863 ·Status: COMPLETED ·Phase: PHASE2

A Study of AMDX-2011P in Participants With Alzheimer's Disease

NCT06514001 ·Status: RECRUITING ·Phase: PHASE2

Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

NCT01864655 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

NCT00795418 ·Status: COMPLETED ·Phase: PHASE2

Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease

NCT02359864 ·Status: TERMINATED ·Phase: NA

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

NCT00956410 ·Status: COMPLETED ·Phase: PHASE2

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

NCT00329082 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

NCT02624778 ·Status: COMPLETED ·Phase: PHASE1

TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease

NCT03539380 ·Status: AVAILABLE

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

NCT05399888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

NCT01094340 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study

NCT03748303 ·Status: TERMINATED ·Phase: PHASE1